Skip to main content
Cureus logoLink to Cureus
. 2020 Jun 17;12(6):c32. doi: 10.7759/cureus.c32

Correction: Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy

Tulay Eren 1,, Lale Pasaoglu 2
Editors: Alexander Muacevic, John R Adler
PMCID: PMC7301424  PMID: 32566431

A decimal point was erroneously included in the initial manuscript submission. This error was, regrettably, not caught during peer or editorial review. As a result, the decimal point has been removed from "94.4 mg/m2" as seen in the following sentence located in the results section: "The optimum cut-off value for age was 60 years, sensitivity 60% and specificity 56%; the same values for cumulative oxaliplatin dosage were, respectively, 94.4 mg/m2, 72%, and 68%."

The corrected sentence now reads: "The optimum cut-off value for age was 60 years, sensitivity 60% and specificity 56%; the same values for cumulative oxaliplatin dosage were, respectively, 944 mg/m2, 72%, and 68%."

Cureus sincerely regrets this error.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

Footnotes

No competing interests declared.


Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES